Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Jilin Xidian Pharmaceutical Technology Development Co., Ltd. (stock code: 301130) is a technology-based pharmaceutical enterprise specializing in the research and development, production, and sales of chemical drug raw materials and preparations. It was one of the first pharmaceutical enterprises in Jilin Province to be recognized as "high-tech enterprises" in 2008. And has been successively rated as a "National High tech Enterprise" and "Key High tech Enterprise of the National Torch Plan". After more than 30 years of differentiated development, the company has formed a product system centered on anti-anemia drugs, drugs for treating mental disorders, and raw materials, with cardiovascular and cerebrovascular disease treatment drugs and anti-tumor treatment drugs as auxiliary products.
Headquarter Jilin
Establish Date 3/21/1990
Listed Code 301130.SZ
Listed Date 2/23/2022
Chairman Zhang Jun.
CEO Zhang Jun.
Website www.xidianyy.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial